Teva supplies more medicines to the NHS than anyone else1 and a large proportion of those medicines are packed at our packaging site in Eastbourne. In fact, around three billion tablets and capsules are packed there every year.2
For the last four years, we’ve been hosting tours for groups of Pre-registration Pharmacy trainees and Pharmacy Apprentices from Eastbourne District General Hospital.
Guests are taken on a fact-finding mission around our solid-dose packaging facility, where they learn about the packaging process and how Teva ensures our finished packs comply with all relevant regulations, including the new Falsified Medicines Directive.*
They hear about how we develop, produce and market high quality generic medicines, as well as innovative and specialty pharmaceuticals and over-the-counter consumer healthcare products. It surprises them to learn that generic medicines save the NHS more than £13 billion a year in just England and Wales,3 and that more than two thirds of the medicines dispensed by the NHS are generics, yet they cost less than one third of the NHS drugs bill.4
We also talk to them about how Teva’s medicine packaging design aims to help reduce the risk of dispensing errors and make it easier for patients to identify the right medicine.
The coloured circles, clear dark font and white uncluttered box are all intended to help reduce confusion over different medicines and different strengths of the same medicine – both for the patients taking the treatments, but also the pharmacy staff who dispense the medicines.
Photo: Teva's medicines moving through a packaging process
Photo: Teva's medicines at the end of the packaging process
The East Sussex team members which included Tracy Hedley, Lead Technician, Education & Training East Sussex Healthcare NHS Trust, Pharmacy Department and Audrey Haddon, Lead Pharmacist for Education and Training were later recognised for these initiatives during a Quality Day run by Health Education England (HEE). This is the national leadership organisation for education, training and workforce development in the UK’s health sector.
The event involved Educational Programme Directors from across the region meeting to share good practice and develop education and training for the year ahead.
During the event, Eastbourne District General Hospital was recognised regionally by HEE for the way it’s been working collaboratively with Teva at Eastbourne. One session focused on ‘Integrated Education’, looking at the trusts which offer additional external placements to help enrich the learners’ experience, which Eastbourne hospital does, including with Teva.
Tracy Hedley, Lead Technician, Education & Training East Sussex Healthcare NHS Trust, Pharmacy Department said: “This collaboration benefits both organisations and is thanks to good communication and a great working relationship which has built up over the years between us. The hospital’s relationship with Teva was described as ‘above and beyond’ anything anyone else was doing in the region.”
Mark added: “News of this innovative, collaborative approach is now spreading into the wider NHS which means that more cross-party initiatives could be opening up in 2019.”
1 & 2. Teva UK Limited - Data on file.
3 & 4. British Generics Manufacturers Association – About us. https://www.britishgenerics.co.uk/about-generics Accessed 18.02.2019
*The EU Directive on Falsified Medicines (2011/62/EU) aims to combat the issue of false or counterfeit medicine entering the proper supply chain.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global leader in generic medicines, with innovative treatments in select areas, including CNS, pain and respiratory. We deliver high-quality generic products and medicines in nearly every therapeutic area to address unmet patient needs. We have an established presence in generics, specialty, OTC and API, building on more than a century-old legacy, with a fully integrated R&D function, strong operational base and global infrastructure and scale. We strive to act in a socially and environmentally responsible way. Headquartered in Israel, with production and research facilities around the globe, we employ 45,000 professionals, committed to improving the lives of millions of patients. Learn more at www.tevapharm.com.
Date of preparation: February 2019